Total Payments
$2,434
2024 Payments
$50.09
Companies
19
Transactions
146
Medicare Patients
21,654
Medicare Billing
$567,552
Payment Breakdown by Category
Food & Beverage$2,403 (98.7%)
Education$30.80 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,403 | 143 | 98.7% |
| Education | $30.80 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $645.44 | 42 | $0 (2021) |
| Gilead Sciences, Inc. | $442.17 | 38 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $267.24 | 16 | $0 (2024) |
| Abbott Laboratories | $225.57 | 5 | $0 (2023) |
| PFIZER INC. | $183.57 | 13 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $121.58 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $98.92 | 8 | $0 (2019) |
| Boston Scientific Corporation | $65.50 | 2 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $63.76 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $57.05 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.09 | 3 | Janssen Scientific Affairs, LLC ($20.65) |
| 2023 | $185.63 | 4 | Abbott Laboratories ($149.52) |
| 2022 | $42.38 | 2 | E.R. Squibb & Sons, L.L.C. ($42.38) |
| 2021 | $228.74 | 6 | E.R. Squibb & Sons, L.L.C. ($84.81) |
| 2020 | $29.63 | 2 | Janssen Pharmaceuticals, Inc ($29.63) |
| 2019 | $523.65 | 31 | Janssen Pharmaceuticals, Inc ($203.49) |
| 2018 | $625.40 | 44 | Janssen Pharmaceuticals, Inc ($135.29) |
| 2017 | $748.19 | 54 | Gilead Sciences Inc ($325.10) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Cardiovascular | ||||||
| 04/03/2024 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/26/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $53.99 | General |
| Category: Vascular | ||||||
| 09/13/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/11/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $95.53 | General |
| Category: Heart Failure | ||||||
| 03/16/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/26/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.29 | General |
| Category: Cardiovascular | ||||||
| 03/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: Cardiovascular | ||||||
| 10/13/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Cardiovascular | ||||||
| 10/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $74.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $50.65 | General |
| Category: Heart Failure | ||||||
| 05/07/2021 | PFIZER INC. | VYNDAMAX (Drug) | Education | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/24/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $59.53 | General |
| Category: Cardiovascular | ||||||
| 03/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Cardiovascular | ||||||
| 06/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Cardiovascular | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/03/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $36.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 4,533 | 5,309 | $477,468 | $130,446 |
| 2022 | 26 | 6,201 | 8,186 | $599,773 | $154,765 |
| 2021 | 23 | 5,942 | 7,880 | $564,691 | $145,197 |
| 2020 | 26 | 4,978 | 6,320 | $645,788 | $137,144 |
Total Patients
21,654
Total Services
27,695
Medicare Billing
$567,552
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 471 | 554 | $108,584 | $47,993 | 44.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,868 | 2,505 | $97,695 | $15,090 | 15.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 298 | 298 | $52,414 | $13,940 | 26.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 162 | 162 | $28,350 | $8,321 | 29.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 124 | 124 | $25,172 | $6,658 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 41 | $15,949 | $5,560 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 87 | $11,571 | $5,083 | 43.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 79 | $12,640 | $4,885 | 38.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $11,388 | $3,967 | 34.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 366 | 372 | $37,944 | $3,552 | 9.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,224 | $3,016 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $6,698 | $2,735 | 40.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 368 | 386 | $15,054 | $2,099 | 13.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $5,168 | $1,408 | 27.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 46 | 47 | $4,653 | $891.02 | 19.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 90 | 90 | $10,350 | $859.52 | 8.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 47 | 48 | $4,752 | $794.17 | 16.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 38 | 39 | $2,028 | $658.80 | 32.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 28 | 29 | $1,626 | $564.76 | 34.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 42 | 42 | $3,234 | $531.24 | 16.4% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 38 | 39 | $1,173 | $326.52 | 27.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 18 | 18 | $2,196 | $279.65 | 12.7% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 28 | 29 | $881.00 | $253.96 | 28.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 42 | 44 | $2,728 | $239.51 | 8.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $1,290 | $207.00 | 16.0% |
About Dr. Shaiful Islam, MD
Dr. Shaiful Islam, MD is a Nuclear Cardiology healthcare provider based in Chambersburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477577526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shaiful Islam, MD has received a total of $2,434 in payments from pharmaceutical and medical device companies, with $50.09 received in 2024. These payments were reported across 146 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,403).
As a Medicare-enrolled provider, Islam has provided services to 21,654 Medicare beneficiaries, totaling 27,695 services with total Medicare billing of $567,552. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Internal Medicine, Cardiovascular Disease
- Location Chambersburg, PA
- Active Since 07/26/2006
- Last Updated 09/08/2021
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1477577526
Products in Payments
- XARELTO (Drug) $666.09
- ELIQUIS (Drug) $322.75
- CHANTIX (Drug) $109.76
- ABILIFY MAINTENA (Drug) $108.03
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $95.53
- WATCHMAN (Device) $65.50
- MULTAQ (Drug) $62.86
- ENTRESTO (Drug) $57.05
- MITRACLIP (Device) $53.99
- Repatha (Biological) $53.20
- HeartMate 3 Left Ventricular Assist Device (Device) $50.65
- NORTHERA (Drug) $40.60
- LifeVest (Device) $36.82
- BRILINTA (Drug) $36.55
- INJECTAFER (Drug) $36.11
- PRALUENT (Drug) $36.06
- VYNDAMAX (Drug) $18.30
- CAPLYTA (Drug) $14.68
- SAMSCA (Drug) $13.55
- CoreValve Evolut (Device) $13.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.